Literature DB >> 2988402

A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum.

G A Maguire, C P Price.   

Abstract

A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum is described. It is based on the hydrolysis of furylacrylylphenylalanylglycylglycine and applied to an IL Multistat III centrifugal analyser. The method offers better precision and freedom from interference than a fluorimetric assay we have previously described.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2988402     DOI： 10.1177/000456328502200218

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


  9 in total

1.  Why is plasma angiotensin-converting enzyme activity elevated in hyperthyroidism?

Authors:  J E Roulston; A Gold; M Wright; S W Walker
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

2.  The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects.

Authors:  C M Dixon; R W Fuller; P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

3.  ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria.

Authors:  Vahid Felehgari; Zohreh Rahimi; Hadi Mozafari; Asad Vaisi-Raygani
Journal:  Mol Cell Biochem       Date:  2010-09-10       Impact factor: 3.396

4.  The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.

Authors:  Zohreh Rahimi; Vahid Felehgari; Mehrali Rahimi; Hadi Mozafari; Kheirollah Yari; Asad Vaisi-Raygani; Mansour Rezaei; Shohreh Malek-Khosravi; Habibolah Khazaie
Journal:  Mol Biol Rep       Date:  2010-09-19       Impact factor: 2.316

5.  Evaluation of the safety of enalapril in the treatment of heart failure in the very old.

Authors:  C J O'Neill; S G Bowes; C M Sullens; J P Royston; W B Hunt; M J Denham; R J Dobbs; S M Dobbs
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Association of Blood Lead level with Elevated Blood Pressure in Hypertensive Patients.

Authors:  Abdullah A Alghasham; Abdel-Raheim M A Meki; Hisham A S Ismail
Journal:  Int J Health Sci (Qassim)       Date:  2011-01

7.  Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients.

Authors:  C J O'Neill; A Charlett; R J Dobbs; A A Deshmukh; S G Bowes; C Weller; P W Nicholson; J S Milledge; S M Dobbs
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

8.  Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.

Authors:  J C Chan; C S Cockram; M G Nicholls; C K Cheung; R Swaminathan
Journal:  BMJ       Date:  1992-10-24

9.  The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung.

Authors:  James J Meiring; Paul J A Borm; Karim Bagate; Manuela Semmler; Jürgen Seitz; Shinji Takenaka; Wolfgang G Kreyling
Journal:  Part Fibre Toxicol       Date:  2005-06-27       Impact factor: 9.400
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.